BerandaNTRA • NASDAQ
add
Natera Inc
Tutup sebelumnya
$168,17
Rentang hari
$166,75 - $169,88
Rentang tahun
$92,14 - $183,00
Kapitalisasi pasar
23,03Â M USD
Volume Rata-Rata
1,23Â jt
Rasio P/E
-
Hasil dividen
-
Bursa utama
NASDAQ
Dalam berita
Keuangan
Laporan Pendapatan
Pendapatan
Laba bersih
| (USD) | Mar 2025info | Perubahan Y/Y |
|---|---|---|
Pendapatan | 501,83Â jt | 36,46% |
Biaya operasional | 395,94Â jt | 39,95% |
Laba bersih | -66,94Â jt | 0,98% |
Margin laba bersih | -13,34 | 27,42% |
Penghasilan per saham | -0,50 | 10,71% |
EBITDA | -69,94Â jt | -4,00% |
Tarif pajak efektif | -0,26% | — |
Neraca
Total aset
Total liabilitas
| (USD) | Mar 2025info | Perubahan Y/Y |
|---|---|---|
Investasi tunai jangka pdk | 991,60Â jt | 12,31% |
Total aset | 1,73Â M | 17,99% |
Total liabilitas | 492,69Â jt | -26,91% |
Total ekuitas | 1,24 M | — |
Saham yang beredar | 136,55 jt | — |
Harga terhadap nilai buku | 18,44 | — |
Tingkat pengembalian aset | -11,67% | — |
Tingkat pengembalian modal | -14,05% | — |
Arus Kas
Perubahan kas bersih
| (USD) | Mar 2025info | Perubahan Y/Y |
|---|---|---|
Laba bersih | -66,94Â jt | 0,98% |
Kas dari operasi | 44,45Â jt | 64,63% |
Kas dari investasi | -16,82Â jt | -112,16% |
Kas dari pembiayaan | 544,00Â rb | -91,59% |
Perubahan kas bersih | 28,18Â jt | -83,59% |
Arus kas bebas | 17,51Â jt | 319,87% |
Tentang
Natera, Inc. is a clinical genetic testing company based in Austin, Texas that specializes in non-invasive, cell-free DNA testing technology, with a focus on women’s health, cancer, and organ health. Natera’s proprietary technology combines novel molecular biology techniques with a suite of bioinformatics software that allows detection down to a single molecule in a tube of blood. Natera operates CAP-accredited laboratories certified under the Clinical Laboratory Improvement Amendments in San Carlos, California and Austin, Texas. Wikipedia
Didirikan
1 Jan 2004
Kantor pusat
Situs
Karyawan
4.429
